Navigation Links
Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
Date:11/6/2008

BGC 945 Builds Upon a Proven Class of Drugs With Greater Tumor Selectivity

EMERYVILLE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has in-licensed a novel targeted oncology compound, BGC 945, from BTG International Limited based in the United Kingdom. Under the terms of the agreement, Onyx will obtain a worldwide license for BGC 945 and all of its related patents. Onyx will receive exclusive worldwide marketing rights and will be responsible for all product development and commercialization activities. BTG will receive a $13 million upfront payment, and payments of up to $72 million upon the attainment of certain global development and regulatory milestones, plus additional milestone payments upon the achievement of certain marketing approvals and commercial milestones. BTG will also receive royalties on future product sales.

"In-licensing a promising compound, such as BGC 945, with potential application in several large tumor markets strategically strengthens Onyx's pipeline and expands our portfolio as a growing biopharmaceutical company," said Tony Coles, M.D., president and chief executive officer of Onyx. "With proven success in developing and commercializing Nexavar as one of the leading targeted oncology therapies, we are well positioned to maximize BGC 945's full potential in a variety of tumors."

BGC 945 (ONX 0801) is designed to work by combining two proven approaches to improving outcomes for cancer patients. These include receptor-mediated targeting of tumor cells and inhibition of thymidylate synthase, a key enzyme involved in cell growth and division. BGC 945 (ONX 0801) targets malignant cells that overexpress the alpha-folate receptor, which is
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
2. ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
3. Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
4. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
6. Onyx Pharmaceuticals to Present at the 2008 Credit Suisse Health Care Conference
7. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
8. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
9. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
10. Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
11. VIA Pharmaceuticals Announces Upcoming Investor Conference Presentations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...irstCall/ -- IES (Nasdaq: IESC ), a leading natio...ems and services for the commercial, industrial an...mmercial business group has been awarded a contrac...al systems for the Level 4 bio-safety lab (BSL-4) ...arch Institute of Infectious Diseases (USAMRIID) a...
(Date:11/24/2009).... 24 Dow AgroSciences Ca... Hyland Seeds, a division of Thompsons Limited of ...ll further expand Dow AgroSciences, current seeds ...on of SmartStax(TM) in 2010 and Dow AgroScie...n 2012. The transactional close is expected in the...
(Date:11/24/2009)...d, November 24 deCODE,ge...pproval of all of its,"first day" motions by the U...(the "Bankruptcy Court"). deCODE last week filed a... the United States Bankruptcy Code with the,Bankru...nkruptcy Court allow the company to continue,to op...
(Date:11/24/2009)...lue Marble Energy Corp. announced today that the c... (OPDA) were recently awarded $2 million by Washin...rd (CERB) in a private/public partnership to const...finery in Lincoln County, WA. ,, "This invest...ur biorefinery and bring over 70 green jobs to Lin...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...oratories, Inc., 2000 Alfred Nobel Drive,Hercul..., Capillary sequencing technology has alte...hroughput and automating the sequencing process. T... a standard in production laboratories, driving su...e Human Genome Project. , One of the requi...
...unders and Alan McCarthy , School of Bio...ol, UK, , Introduction , M...typic analysis of naturally-occurring , a...lecular biological , techniques that enab...irectly , from the environment. The ubiqu...
...io-Rad Laboratories, 2000 Alfred Nobel Drive,He...dford and Lowry assays are 2 colorimetric assays t...tein concentration. Bio-Rads protein assay (catalo...-binding assay (Bradford 1976), measures , ...is used for protein concentrations , rang...
Other Biology Technology:Comparison of Commercial Dye Terminator Removal Kits, Rev A 2Comparison of Commercial Dye Terminator Removal Kits, Rev A 3Comparison of Commercial Dye Terminator Removal Kits, Rev A 4Comparison of Commercial Dye Terminator Removal Kits, Rev A 5Monitoring Bacterial Genetic Diversity in a Freshwater Lake Using TTGE and DNA Sequence Analysis 2Monitoring Bacterial Genetic Diversity in a Freshwater Lake Using TTGE and DNA Sequence Analysis 3Monitoring Bacterial Genetic Diversity in a Freshwater Lake Using TTGE and DNA Sequence Analysis 4Benchmark Plus Microplate Reader: Quantitation of Protein Concentration Using Two Different Colorimetric Assay Kits, Rev A 2Benchmark Plus Microplate Reader: Quantitation of Protein Concentration Using Two Different Colorimetric Assay Kits, Rev A 3Benchmark Plus Microplate Reader: Quantitation of Protein Concentration Using Two Different Colorimetric Assay Kits, Rev A 4
(Date:11/25/2009)...ll Death Research Laboratory in the University of ...e prestigious Johnson & Johnson Focused Funding gr...cell damage in Parkinson,s disease. The award, whi...f innovation and excellence in science, was announ... month at an event at the Hyatt Regency Hotel in N...
(Date:11/25/2009)... professors recently received funding from the Nat...h beneficial to understanding the environment. The...kwood, assistant professor in the Department of Bi...wo separate research projects. , His first proje...es and Functions from the Leaf to the Landscape," ...
(Date:11/24/2009)...today named 12 new grant recipients for 2009. The ...e work across a broad spectrum of lupus research. ...nd potential to drive scientific discovery to ulti...e of systemic lupus. , The 2009 grants go to bot... nation and include interdisciplinary and highly p...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Annual Scrapbooking Event in Oceanside October 17 and 18 to Benefit Susan G Komen for the Cure 59010 1Annual Scrapbooking Event in Oceanside October 17 and 18 to Benefit Susan G Komen for the Cure 59010 2Annual Scrapbooking Event in Oceanside October 17 and 18 to Benefit Susan G Komen for the Cure 59010 3Physiotherapy Associates Marks National Physical Therapy Month With Free Educational Brochure 5277 1Physiotherapy Associates Marks National Physical Therapy Month With Free Educational Brochure 5277 2Formatta Presents Forms Driven Business Process Optimization Webinar for Healthcare on Wednesday October 14 at 1 p m Eastern 59004 1Formatta Presents Forms Driven Business Process Optimization Webinar for Healthcare on Wednesday October 14 at 1 p m Eastern 59004 2
...a, Calif.) Scientists at UC Santa Barbara have ma...y human embryonic stem cells function. , They exp...ls will renew, or will transform to become part of...ody. The study is reported in the May 1 issue of t...ng bodes well for cancer research, since tumor ste...
...ad simulation has emphasized that flu intervention...tive. Researchers writing in the open access journ...home, closing schools and isolating infected peopl...y if they are used in combination, activated witho...od. , Professor George Milne and his colleagues f...
...tured on the cover of the May issue of The FASEB ...o reprogram human adult skin cells into other cell... underlying reprogramming. To demonstrate their po...muscle cells and vice versa. This research shows t...lization it may be possible to convert one cell ty...
Other Biology News:Scientists shed light on inner workings of human embryonic stem cells 2Scientists shed light on inner workings of human embryonic stem cells 3Social separation stops flu spread, but must be started soon 2Stanford scientists turn adult skin cells into muscle and vice versa 2
GIBCO Keratinocyte-SFM (1X) liquid from Invitrogen
GIBCO Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid from Invitrogen
GIBCO Penicillin-Streptomycin liquid from Invitrogen
GIBCO Streptomycin Sulfate from Invitrogen
Biology Products: